Sources, metabolism, and regulation of circulating sphingosine-1-phosphate

Journal of Lipid Research

Volumn 56, Issue 7, 2015, Pages 1271-1281

  Ksia¸zek, Monika ^a   Chacińska, Marta ^a   Chabowski, Adrian ^a   Baranowski, Marcin ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Dihydrosphingosine 1 phosphate; Endothelial cells; High density lipoprotein; Red blood cells; Thrombocytes

Indexed keywords

ALBUMIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; VERY LOW DENSITY LIPOPROTEIN; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

BLOOD CELL; BLOOD VESSEL FUNCTION; BLOOD VESSEL TONE; CELLULAR DISTRIBUTION; ENDOTHELIAL BARRIER FUNCTION; ERYTHROCYTE; HUMAN; LEUKOCYTE; LIPID BLOOD LEVEL; LIPID DEGRADATION; LIPID HOMEOSTASIS; LIPID METABOLISM; LIPID SOURCE; LIPID TRANSPORT; LIPOGENESIS; LIVER CELL; LYMPHOCYTE MIGRATION; METABOLIC REGULATION; NONHUMAN; PLASMA CLEARANCE; PLASMA HALF LIFE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; VASCULAR ENDOTHELIUM; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; METABOLISM;

ANIMALS; BLOOD CELLS; HUMANS; LYSOPHOSPHOLIPIDS; SPHINGOSINE;

EID: 84937112643     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R059543     Document Type: Review

References (109)

1. Saba, J. D., and T. Hla. 2004. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ. Res. 94: 724-734.
2. Takabe, K., S. W. Paugh, S. Milstien, and S. Spiegel. 2008. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol. Rev. 60: 181-195.
3. Tabasinezhad, M., N. Samadi, P. Ghanbari, M. Mohseni, A. A. Saei, S. Sharifi, N. Saeedi, and A. Pourhassan. 2013. Sphingosine 1-phosphate contributes in tumor progression. J. Cancer Res. Ther. 9: 556-563.
4. Maceyka, M., K. B. Harikumar, S. Milstien, and S. Spiegel. 2012. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 22: 50-60.
5. Knapp, M. 2011. Cardioprotective role of sphingosine-1-phosphate. J. Physiol. Pharmacol. 62: 601-607.
6. Simmons, S., and M. Ishii. 2014. Sphingosine-1-phosphate: a master regulator of lymphocyte egress and immunity. Arch. Immunol. Ther. Exp. (Warsz.). 62: 103-115.
7. Wilkerson, B. A., and K. M. Argraves. 2014. The role of sphingosine-1-phosphate in endothelial barrier function. Biochim. Biophys. Acta. 1841: 1403-1412.
8. Kerage, D., D. N. Brindley, and D. G. Hemmings. 2014. Review: novel insights into the regulation of vascular tone by sphingosine 1-phosphate. Placenta. 35 (Suppl) : S86-S92.
9. Kikuta, J., S. Kawamura, F. Okiji, M. Shirazaki, S. Sakai, H. Saito,and M. Ishii. 2013. Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. Proc. Natl. Acad. Sci. USA. 110: 7009-7013.
10. Kohama, T., A. Olivera, L. Edsall, M. M. Nagiec, R. Dickson, and S. Spiegel. 1998. Molecular cloning and functional characterization of murine sphingosine kinase. J. Biol. Chem. 273: 23722-23728.
11. Chan, H., and S. M. Pitson. 2013. Post-translational regulation of sphingosine kinases. Biochim. Biophys. Acta. 1831: 147-156.
12. Ancellin, N., C. Colmont, J. Su, Q. Li, N. Mittereder, S. S. Chae,S. Stefansson, G. Liau, and T. Hla. 2002. Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J. Biol. Chem. 277: 6667-6675.
13. Igarashi, N., T. Okada, S. Hayashi, T. Fujita, S. Jahangeer, and S. Nakamura. 2003. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J. Biol. Chem. 278: 46832-46839.
14. Venkataraman, K., S. Thangada, J. Michaud, M. L. Oo, Y. Ai, Y. M. Lee, M. Wu, N. S. Parikh, F. Khan, R. L. Proia, et al. 2006. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem. J. 397: 461-471.
15. Liu, H., M. Sugiura, V. E. Nava, L. C. Edsall, K. Kono, S. Poulton,S. Milstien, T. Kohama, and S. Spiegel. 2000. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 275: 19513-19520.
16. Liu, X., Q. H. Zhang, and G. H. Yi. 2012. Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells. Mol. Cell. Biochem. 363: 21-33.
17. Bandhuvula, P., and J. D. Saba. 2007. Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren. Trends Mol. Med. 13: 210-217.
18. Mandala, S. M. 2001. Sphingosine-1-phosphate phosphatases. Prostaglandins Other Lipid Mediat. 64: 143-156.
19. Nanjundan, M., and F. Possmayer. 2001. Pulmonary lipid phosphate phosphohydrolase in plasma membrane signalling platforms. Biochem. J. 358: 637-646.
20. Kai, M., F. Sakane, Y. J. Jia, S. Imai, S. Yasuda, and H. Kanoh. 2006. Lipid phosphate phosphatases 1 and 3 are localized in distinct lipid rafts. J. Biochem. 140: 677-686.
21. Alderton, F., P. Darroch, B. Sambi, A. McKie, I. S. Ahmed, N. Pyne, and S. Pyne. 2001. G-protein-coupled receptor stimulation of the p42/p44 mitogen-activated protein kinase pathway is attenuated by lipid phosphate phosphatases 1, 1a, and 2 in human embryonic kidney 293 cells. J. Biol. Chem. 276: 13452-13460.
22. Zhao, Y., S. K. Kalari, P. V. Usatyuk, I. Gorshkova, D. He, T. Watkins, D. N. Brindley, C. Sun, R. Bittman, J. G. Garcia, et al. 2007. Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J. Biol. Chem. 282: 14165-14177.
23. Jasinska, R., Q. X. Zhang, C. Pilquil, I. Singh, J. Xu, J. Dewald,D. A. Dillon, L. G. Berthiaume, G. M. Carman, D. W. Waggoner,et al. 1999. Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and sphingolipid phosphate esters. Biochem. J. 340: 677-686.
24. Mechtcheriakova, D., A. Wlachos, J. Sobanov, F. Bornancin, G. Zlabinger, T. Baumruker, and A. Billich. 2007. FTY720-phosphate is dephosphorylated by lipid phosphate phosphatase 3. FEBS Lett. 581: 3063-3068.
25. Yatomi, Y., S. Yamamura, N. Hisano, K. Nakahara, Y. Igarashi, and Y. Ozaki. 2004. Sphingosine 1-phosphate breakdown in platelets. J. Biochem. 136: 495-502.
26. Anada, Y., Y. Igarashi, and A. Kihara. 2007. The immunomodulator FTY720 is phosphorylated and released from platelets. Eur. J. Pharmacol. 568: 106-111.
27. Fukuda, Y., A. Kihara, and Y. Igarashi. 2003. Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1. Biochem. Biophys. Res. Commun. 309: 155-160.
28. Tani, M., T. Sano, M. Ito, and Y. Igarashi. 2005. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. J. Lipid Res. 46: 2458-2467.
29. Simon, C. G., S. Chatterjee, and A. R. Gear. 1998. Sphingomyelinase activity in human platelets. Thromb. Res. 90: 155-161.
30. Marathe, S., S. L. Schissel, M. J. Yellin, N. Beatini, R. Mintzer, K. J. Williams, and I. Tabas. 1998. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J. Biol. Chem. 273: 4081-4088.
31. Pienimaeki-Roemer, A., K. Ruebsaamen, A. Boettcher, E. Orsó, M. Scherer, G. Liebisch, D. Kilalic, N. Ahrens, and G. Schmitz. 2013. Stored platelets alter glycerophospholipid and sphingolipid species, which are differentially transferred to newly released extracellular vesicles. Transfusion. 53: 612-626.
32. Smyth, S. S., V. A. Sciorra, Y. J. Sigal, Z. Pamuklar, Z. Wang, Y. Xu,G. D. Prestwich, and A. J. Morris. 2003. Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity. J. Biol. Chem. 278: 43214-43223.
33. Ito, K., Y. Anada, M. Tani, M. Ikeda, T. Sano, A. Kihara, and Y. Igarashi. 2007. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem. Biophys. Res. Commun. 357: 212-217.
34. Kihara, A., and Y. Igarashi. 2008. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. Biochim. Biophys. Acta. 1781: 496-502.
35. Awojoodu, A. O., P. M. Keegan, A. R. Lane, Y. Zhang, K. R. Lynch,M. O. Platt, and E. A. Botchwey. 2014. Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD. Blood. 124: 1941-1950.
36. Xu, R., W. Sun, J. Jin, L. M. Obeid, and C. Mao. 2010. Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes. FASEB J. 24: 2507-2515.
37. López, D. J., M. Egido-Gabas, I. López-Montero, J. V. Busto, J. Casas, M. Garnier, F. Monroy, B. Larijani, F. M. Goñi, and A. Alonso. 2012. Accumulated bending energy elicits neutral sphingomyelinase activity in human red blood cells. Biophys. J. 102: 2077-2085.
38. Hänel, P., P. Andréani, and M. H. Gräler. 2007. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J. 21: 1202-1209.
39. Selim, S., M. Sunkara, A. K. Salous, S. W. Leung, E. V. Berdyshev, A. Bailey, C. L. Campbell, R. Charnigo, A. J. Morris, and S. S. Smyth. 2011. Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. Clin. Sci. (Lond.). 121: 565-572.
40. Knapp, M., A. Lisowska, P. Zabielski, W. Musiał, and M. Baranowski. 2013. Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction. Prostaglandins Other Lipid Mediat. 106: 53-61.
41. Yang, L., Y. Yatomi, Y. Miura, K. Satoh, and Y. Ozaki. 1999. Metabolism and functional effects of sphingolipids in blood cells. Br. J. Haematol. 107: 282-293.
42. Dedov, V. N., I. V. Dedova, and G. A. Nicholson. 2004. Hypoxia causes aggregation of serine palmitoyltransferase followed by non-apoptotic death of human lymphocytes. Cell Cycle. 3: 1271-1277.
43. Ibrahim, F. B., S. J. Pang, and A. J. Melendez. 2004. Anaphylatoxin signaling in human neutrophils. A key role for sphingosine kinase. J. Biol. Chem. 279: 44802-44811.
44. Yatomi, Y., Y. Igarashi, L. Yang, N. Hisano, R. Qi, N. Asazuma, K. Satoh, Y. Ozaki, and S. Kume. 1997. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. 121: 969-973.
45. Schwab, S. R., and J. G. Cyster. 2007. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 8: 1295-1301.
46. Knapp, P., M. Baranowski, M. Knapp, P. Zabielski, A. U. Błachnio-Zabielska, and J. Górski. 2010. Altered sphingolipid metabolism in human endometrial cancer. Prostaglandins Other Lipid Mediat. 92: 62-66.
47. Kułakowska, A., M. Zendzian-Piotrowska, M. Baranowski, T. Konoñczuk, W. Drozdowski, J. Górski, and R. Bucki. 2010. Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis. Neurosci. Lett. 477: 149-152.
48. Baranowski, M., M. Charmas, B. Długołȩcka, and J. Górski. 2011. Exercise increases plasma levels of sphingoid base-1 phosphates in humans. Acta Physiol. (Oxf.). 203: 373-380.
49. Knapp, M., M. Baranowski, A. Lisowska, and W. Musiał. 2012. Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure. Adv. Med. Sci. 57: 100-105.
50. Knapp, M., A. Lisowska, P. Knapp, and M. Baranowski. 2013. Dose-dependent effect of aspirin on the level of sphingolipids in human blood. Adv. Med. Sci. 58: 274-281.
51. Baranowski, M., J. Górski, B. Klapcinska, Z. Waskiewicz, and E. Sadowska-Krepa. 2014. Ultramarathon run markedly reduces plasma sphingosine-1-phosphate concentration. Int. J. Sport Nutr. Exerc. Metab. 24: 148-156.
52. Hammad, S. M., J. S. Pierce, F. Soodavar, K. J. Smith, M. M. Al Gadban, B. Rembiesa, R. L. Klein, Y. A. Hannun, J. Bielawski,and A. Bielawska. 2010. Blood sphingolipidomics in healthy humans: impact of sample collection methodology. J. Lipid Res. 51: 3074-3087.
53. Andréani, P., and M. H. Gräler. 2006. Comparative quantification of sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction. Anal. Biochem. 358: 239-246.
54. Sattler, K. J., S. Elbasan, P. Keul, M. Elter-Schulz, C. Bode, M. H. Gräler, M. Bröcker-Preuss, T. Budde, R. Erbel, G. Heusch, et al. 2010. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res. Cardiol. 105: 821-832.
55. Hammad, S. M., M. M. Al Gadban, A. J. Semler, and R. L. Klein. 2012. Sphingosine 1-phosphate distribution in human plasma: associations with lipid profiles. J. Lipids. 2012: 180705.
56. Karuna, R., R. Park, A. Othman, A. G. Holleboom, M. M. Motazacker, I. Sutter, J. A. Kuivenhoven, L. Rohrer, H. Matile, T. Hornemann, et al. 2011. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. Atherosclerosis. 219: 855-863.
57. Venkataraman, K., Y. M. Lee, J. Michaud, S. Thangada, Y. Ai, H. L. Bonkovsky, N. S. Parikh, C. Habrukowich, and T. Hla. 2008. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ. Res. 102: 669-676.
58. Hisano, Y., N. Kobayashi, A. Yamaguchi, and T. Nishi. 2012. Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS ONE. 7: e38941.
59. Murata, N., K. Sato, J. Kon, H. Tomura, M. Yanagita, A. Kuwabara,M. Ui, and F. Okajima. 2000. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 352: 809-815.
60. Caligan, T. B., K. Peters, J. Ou, E. Wang, J. Saba, and A. H. Merrill. 2000. A high-performance liquid chromatographic method to measure sphingosine 1-phosphate and related compounds from sphingosine kinase assays and other biological samples. Anal. Biochem. 281: 36-44.
61. Kowalski, G. M., A. L. Carey, A. Selathurai, B. A. Kingwell, and C. R. Bruce. 2013. Plasma sphingosine-1-phosphate is elevated in obesity. PLoS ONE. 8: e72449.
62. Ohkawa, R., K. Nakamura, S. Okubo, S. Hosogaya, Y. Ozaki, M. Tozuka, N. Osima, H. Yokota, H. Ikeda, and Y. Yatomi. 2008. Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters. Ann. Clin. Biochem. 45: 356-363.
63. Guo, S., Y. Yu, N. Zhang, Y. Cui, L. Zhai, H. Li, Y. Zhang, F. Li, Y. Kan, and S. Qin. 2014. Higher level of plasma bioactive molecule sphingosine 1-phosphate in women is associated with estrogen. Biochim. Biophys. Acta. 1841: 836-846.
64. Okajima, F. 2002. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim. Biophys. Acta. 1582: 132-137.
65. Argraves, K. M., A. A. Sethi, P. J. Gazzolo, B. A. Wilkerson, A. T. Remaley, A. Tybjaerg-Hansen, B. G. Nordestgaard, S. D. Yeatts, K. S. Nicholas, J. L. Barth, et al. 2011. S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids Health Dis. 10: 70.
66. Zhang, B., H. Tomura, A. Kuwabara, T. Kimura, S. Miura, K. Noda, F. Okajima, and K. Saku. 2005. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. Atherosclerosis. 178: 199-205.
67. Hla, T., K. Venkataraman, and J. Michaud. 2008. The vascular S1P gradient-cellular sources and biological significance. Biochim. Biophys. Acta. 1781: 477-482.
68. Christoffersen, C., H. Obinata, S. B. Kumaraswamy, S. Galvani,J. Ahnström, M. Sevvana, C. Egerer-Sieber, Y. A. Muller, T. Hla,L. B. Nielsen, et al. 2011. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc. Natl. Acad. Sci. USA. 108: 9613-9618.
69. Sutter, I., R. Park, A. Othman, L. Rohrer, T. Hornemann, M. Stoffel, O. Devuyst, and A. von Eckardstein. 2014. Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate. J. Lipid Res. 55: 1730-1737.
70. Sevvana, M., J. Ahnström, C. Egerer-Sieber, H. A. Lange, B. Dahlbäck, and Y. A. Muller. 2009. Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M. J. Mol. Biol. 393: 920-936.
71. Kimura, T., K. Sato, A. Kuwabara, H. Tomura, M. Ishiwara, I. Kobayashi, M. Ui, and F. Okajima. 2001. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J. Biol. Chem. 276: 31780-31785.
72. Theilmeier, G., C. Schmidt, J. Herrmann, P. Keul, M. Schäfers,I. Herrgott, J. Mersmann, J. Larmann, S. Hermann, J. Stypmann,et al. 2006. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation. 114: 1403-1409.
73. Wilkerson, B. A., G. D. Grass, S. B. Wing, W. S. Argraves, and K. M. Argraves. 2012. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. J. Biol. Chem. 287: 44645-44653.
74. Salous, A. K., M. Panchatcharam, M. Sunkara, P. Mueller, A. Dong, Y. Wang, G. A. Graf, S. S. Smyth, and A. J. Morris. 2013. Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice. J. Lipid Res. 54: 2775-2784.
75. Aoki, S., Y. Yatomi, M. Ohta, M. Osada, F. Kazama, K. Satoh, K. Nakahara, and Y. Ozaki. 2005. Sphingosine 1-phosphate-related metabolism in the blood vessel. J. Biochem. 138: 47-55.
76. Pappu, R., S. R. Schwab, I. Cornelissen, J. P. Pereira, J. B. Regard,Y. Xu, E. Camerer, Y. W. Zheng, Y. Huang, J. G. Cyster, et al. 2007. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science. 316: 295-298.
77. Kharel, Y., M. Raje, M. Gao, A. M. Gellett, J. L. Tomsig, K. R. Lynch, and W. L. Santos. 2012. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. Biochem. J. 447: 149-157.
78. Kharel, Y., T. P. Mathews, A. M. Gellett, J. L. Tomsig, P. C. Kennedy, M. L. Moyer, T. L. Macdonald, and K. R. Lynch. 2011. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. Biochem. J. 440: 345-353.
79. Sensken, S. C., C. Bode, M. Nagarajan, U. Peest, O. Pabst, and M. H. Gräler. 2010. Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia. J. Immunol. 184: 4133-4142.
80. Tani, M., M. Ito, and Y. Igarashi. 2007. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell. Signal. 19: 229-237.
81. Bode, C., S. C. Sensken, U. Peest, G. Beutel, F. Thol, B. Levkau,Z. Li, R. Bittman, T. Huang, M. Tölle, et al. 2010. Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. J. Cell. Biochem. 109: 1232-1243.
82. Dong, A., M. Sunkara, M. Panchatcharam, A. Salous, S. Selim, A. J. Morris, and S. S. Smyth. 2012. Synergistic effect of anemia and red blood cells transfusion on inflammation and lung injury. Adv. Hematol. 2012: 924042.
83. Kobayashi, N., A. Yamaguchi, and T. Nishi. 2009. Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J. Biol. Chem. 284: 21192-21200.
84. Yu, Y., S. Guo, Y. Feng, L. Feng, Y. Cui, G. Song, T. Luo, K. Zhang,Y. Wang, X. C. Jiang, et al. 2014. Phospholipid transfer protein deficiency decreases the content of S1P in HDL via the loss of its transfer capability. Lipids. 49: 183-190.
85. Nagahashi, M., K. Takabe, K. P. Terracina, D. Soma, Y. Hirose,T. Kobayashi, Y. Matsuda, and T. Wakai. 2014. Sphingosine-1-phosphate transporters as targets for cancer therapy. Biomed. Res. Int. 2014: 651727.
86. Mendoza, A., B. Bréart, W. D. Ramos-Perez, L. A. Pitt, M. Gobert,M. Sunkara, J. J. Lafaille, A. J. Morris, and S. R. Schwab. 2012. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Reports. 2: 1104-1110.
87. Fukuhara, S., S. Simmons, S. Kawamura, A. Inoue, Y. Orba, T. Tokudome, Y. Sunden, Y. Arai, K. Moriwaki, J. Ishida, et al. 2012. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J. Clin. Invest. 122: 1416-1426.
88. Lee, Y. M., K. Venkataraman, S. I. Hwang, D. K. Han, and T. Hla. 2007. A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). Prostaglandins Other Lipid Mediat. 84: 154-162.
89. Jonnalagadda, D., M. Sunkara, A. J. Morris, and S. W. Whiteheart. 2014. Granule-mediated release of sphingosine-1-phosphate by activated platelets. Biochim. Biophys. Acta. 1841: 1581-1589.
90. Ulrych, T., A. Böhm, A. Polzin, G. Daum, R. M. Nüsing, G. Geisslinger, T. Hohlfeld, K. Schrör, and B. H. Rauch. 2011. Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. J. Thromb. Haemost. 9: 790-798.
91. Yatomi, Y., T. Ohmori, G. Rile, F. Kazama, H. Okamoto, T. Sano,K. Satoh, S. Kume, G. Tigyi, Y. Igarashi, et al. 2000. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood. 96: 3431-3438.
92. Sano, T., D. Baker, T. Virag, A. Wada, Y. Yatomi, T. Kobayashi,Y. Igarashi, and G. Tigyi. 2002. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J. Biol. Chem. 277: 21197-21206.
93. Kobayashi, N., T. Nishi, T. Hirata, A. Kihara, T. Sano, Y. Igarashi,and A. Yamaguchi. 2006. Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. J. Lipid Res. 47: 614-621.
94. Dahm, F., A. Nocito, A. Bielawska, K. S. Lang, P. Georgiev, L. M. Asmis, J. Bielawski, J. Madon, Y. A. Hannun, and P. A. Clavien. 2006. Distribution and dynamic changes of sphingolipids in blood in response to platelet activation. J. Thromb. Haemost. 4: 2704-2709.
95. Igarashi, Y., and Y. Yatomi. 1998. Sphingosine 1-phosphate is a blood constituent released from activated platelets, possibly playing a variety of physiological and pathophysiological roles. Acta Biochim. Pol. 45: 299-309.
96. Ono, Y., M. Kurano, R. Ohkawa, H. Yokota, K. Igarashi, J. Aoki,M. Tozuka, and Y. Yatomi. 2013. Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration. Lipids Health Dis. 12: 20.
97. Son, D. J., H. W. Lee, H. W. Shin, J. J. Lee, H. S. Yoo, T. J. Kim, Y. P. Yun, and J. T. Hong. 2008. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis. Prostaglandins Leukot. Essent. Fatty Acids. 78: 383-390.
98. Schmidt, H., R. Schmidt, and G. Geisslinger. 2006. LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples. Prostaglandins Other Lipid Mediat. 81: 162-170.
99. Jedlitschky, G., K. Tirschmann, L. E. Lubenow, H. K. Nieuwenhuis,J. W. Akkerman, A. Greinacher, and H. K. Kroemer. 2004. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood. 104: 3603-3610.
100. Olivera, B. M. 2006. Conus peptides: biodiversity-based discovery and exogenomics. J. Biol. Chem. 281: 31173-31177.
101. Mitra, P., C. A. Oskeritzian, S. G. Payne, M. A. Beaven, S. Milstien,and S. Spiegel. 2006. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc. Natl. Acad. Sci. USA. 103: 16394-16399.
102. Nijnik, A., S. Clare, C. Hale, J. Chen, C. Raisen, L. Mottram, M. Lucas, J. Estabel, E. Ryder, H. Adissu, et al. 2012. The role of sphingosine-1-phosphate transporter Spns2 in immune system function. J. Immunol. 189: 102-111.
103. Xiong, Y., P. Yang, R. L. Proia, and T. Hla. 2014. Erythrocyte-derived sphingosine 1-phosphate is essential for vascular development. J. Clin. Invest. 124: 4823-4828.
104. Baranowski, M., A. U. Błachnio-Zabielska, M. Charmas, J. W. Helge,F. Dela, M. Ksia¸żek, B. Długołêcka, A. Klusiewicz, A. Chabowski, and J. Górski. 2015. Exercise increases sphingoid base-1-phosphate levels in human blood and skeletal muscle in a time- and intensity-dependent manner. Eur. J. Appl. Physiol. 115: 993-1003.
105. Kurano, M., K. Tsukamoto, R. Ohkawa, M. Hara, J. Iino, Y. Kageyama, H. Ikeda, and Y. Yatomi. 2013. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. Atherosclerosis. 229: 102-109.
106. Sterner, E., S. Masuko, G. Li, L. Li, D. E. Green, N. J. Otto, Y. Xu,P. L. DeAngelis, J. Liu, J. S. Dordick, et al. 2014. Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printing. J. Biol. Chem. 289: 9754-9765.
107. Ikeda, H., R. Ohkawa, N. Watanabe, K. Nakamura, Y. Kume, H. Nakagawa, H. Yoshida, S. Okubo, H. Yokota, T. Tomiya, et al. 2010. Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C. Clin. Chim. Acta. 411: 765-770.
108. Xu, N., and B. Dahlbäck. 1999. A novel human apolipoprotein (apoM). J. Biol. Chem. 274: 31286-31290.
109. Nojiri, T., M. Kurano, Y. Tokuhara, S. Ohkubo, M. Hara, H. Ikeda,K. Tsukamoto, and Y. Yatomi. 2014. Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice. J. Diabetes Investig. 5: 639-648.